Inactivation of the SWI/SNF chromatin remodeler gene, α-thalassemia retardation X-linked (ATRX), represents a common glioma-associated molecular alteration with the potential to substantially impact the tumor microenvironment19,20. This evidence concerns the gene ATRX and central nervous system cancer.